Dr. Sudhanshu Kumar Jha is a multidisciplinary researcher and academician working across pharmaceutical sciences, biomedical engineering, nanotechnology, oncology, and innovative medical devices. He currently serves as a Research Associate at the Centre for Integrative Oncology (CIO), All India Institute of Ayurveda (AIIA), Government of India, New Delhi (2025–present).

He also holds leadership and academic roles including:

• Managing Editor, International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL) (2024–present)

• Assistant Professor (Visiting Faculty), SBS Daddu Ji College of Pharmacy, Uttar Pradesh (2024–present)

• Founder, Chairperson & Editor-in-Chief, Scientistic Era (National/International Webinar Platform & IPR Services Firm), established in 2023

He holds multiple academic contributions through teaching, editorial responsibilities, and national–international collaborations in pharmaceutical sciences and allied domains.

Scientific Contributions & Innovations

Dr. Jha has made extensive contributions to scientific innovation, particularly in medical-device design, nano-formulations, drug delivery technologies, and Ayurveda-integrated modern therapeutics.

His achievements include:

• 4 International Design Patents (UK) granted for advanced biomedical devices including a hematology analyzer, smart thermocycler, temperature-sensitive syringe, and smart drug-release system.

• 10 Indian Design Patents (Granted) for medical diagnostics, therapeutic devices, and pharmaceutical technology innovations.

• 9 Published Patents (Applicant + Inventor) covering phytosome formulations, nano-emulgels, polymeric nanoparticles, nanogels, anticonvulsant compositions, and antimicrobial chalcone derivatives.

• 4 Registered Copyrights on pharmaceutical innovations, drug-delivery mechanisms, and Ayurvedic formulations.

• 13 Scientific Publications, multiple edited books, and numerous published book chapters in pharmacology, herbal sciences, analytical chemistry, and modern forensic applications.

Leadership in Scientific Events and Webinars

As Organizing Secretary of Scientistic Era, Dr. Jha has chaired and organized multiple national and international webinars (2024–2025) focusing on:

• Pharmaceutical policy

• Ayurvedic formulation advancements

• Nano-formulations

• Nutraceutical technologies

• Drug delivery innovations

• AI in pharmaceutical sciences

• Digital forensics
  His scientific events have received recognition from government leaders, academic institutions, and professional bodies.

He has also served as an Expert Speaker on National Entrepreneurship Day (2024) and was invited as a distinguished speaker for the 2nd International Conference on Traditional & Alternative Medicine, to be held in Switzerland (2025).

Awards, Honors & Appreciations

Dr. Jha’s multifaceted contributions have earned him notable recognitions, including:

• Young Researcher Award, Institute of Scholars (INSC)

• Appreciation from the Minister of State (Power & Renewable Energy), Government of India

• Appreciation from Uttarakhand Boxing Association, Uttarakhand Police (SP Vigilance), and MDU Rohtak

• Website inauguration by Shri Shripad Yesso Naik, Minister of Ports, Shipping, Waterways & Tourism, Government of India

• Numerous commendations from journals, conferences, and academic organizations (38 acknowledgments; 60 events attended)

Entrepreneurial & Editorial Leadership

As Founder of Scientistic Era, Dr. Jha established a platform that integrates scientific webinars, research dissemination, and IPR services. His editorial leadership in IJRDPL strengthens global scholarship in pharmaceutical sciences and life-science research.

Eligibility for Nobel Scientist Awards

Dr. Sudhanshu Kumar Jha’s extensive record in pharmaceutical innovation, medical-device design, translational research, and interdisciplinary scientific leadership positions him among researchers whose work demonstrates the calibre associated with major global recognitions.

While the Nobel Prize (often referred to informally as a “Nobel Scientist” recognition) has no nomination by self-application and no official eligibility criteria, scientists with impactful inventions, medically transformative technologies, and international scientific influence are typically considered for such honors.

Dr. Jha’s broad portfolio of patented biomedical devices, published pharmaceutical innovations, cross-disciplinary research, and global academic contributions reflects a scientific profile aligned with the standards of excellence seen in recipients of high-level international scientific awards.